Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis: Study Design and Protocol

NCT07035834 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT07035834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07035834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis: Study Design and Protocol
Lead sponsor
Federico II University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
December 31, 2026
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anca associated vasculitis (aav), lupus nephritis (ln)